Witnessing An Insider Decision, Laetitia Cousin Exercises Options Valued At $89K At Insulet

Disclosed in a recent SEC filing on September 9, Cousin, SVP at Insulet (NASDAQ:PODD), made a noteworthy transaction involving the exercise of company stock options.

What Happened: Cousin, SVP at Insulet, made a strategic move by exercising stock options for 797 shares of PODD as detailed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission. The transaction value amounted to $89,032.

The latest update on Wednesday morning shows Insulet shares down by 0.0%, trading at $352.82. At this price, Cousin's 797 shares are worth $89,032.

Get to Know Insulet Better

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Key Indicators: Insulet's Financial Health

Revenue Growth: Insulet displayed positive results in 3 months. As of 30 June, 2025, the company achieved a solid revenue growth rate of approximately 32.88%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.

Key Insights into Profitability Metrics:

• Gross Margin: With a high gross margin of 69.67%, the company demonstrates effective cost control and strong profitability relative to its peers.

• Earnings per Share (EPS): Insulet's EPS is below the industry average. The company faced challenges with a current EPS of 0.32. This suggests a potential decline in earnings.

Debt Management: With a high debt-to-equity ratio of 0.96, Insulet faces challenges in effectively managing its debt levels, indicating potential financial strain.

Insights into Valuation Metrics:

• Price to Earnings (P/E) Ratio: Insulet's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 107.57.

• Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 10.81 as compared to the industry average, the stock might be considered overvalued based on sales performance.

• EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Insulet's EV/EBITDA ratio of 61.66 exceeds industry averages, indicating a premium valuation in the market

Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Illuminating the Importance of Insider Transactions

Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.

In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.

Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.

Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.

Deciphering Transaction Codes in Insider Filings

Digging into the details of stock transactions, investors frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.

Check Out The Full List Of Insulet's Insider Trades.

Insider Buying Alert: Profit from C-Suite Moves

Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.

This article was generated by Benzinga's automated content engine and reviewed by an editor.